From the very first moments of life, Toby’s journey was marked by uncertainty, fear, and a relentless fight for survival.
Even before he took his first breath, his parents, Jenaya and Josh, faced a storm no expecting parents could ever prepare for.
At 28 weeks into Jenaya’s pregnancy, a routine ultrasound revealed a mass growing on Toby’s arm.
What initially seemed minor soon spiraled into a battle that would test every ounce of resilience in their hearts.
The doctors suggested it might be a hemangioma — a benign birthmark — but warned it could be more serious, even cancerous.
For Jenaya, preparing for a peaceful birth, the news was devastating.
Her mind raced with questions: Could her baby survive in utero? Would the mass rupture? Would they see a heartbeat at the next scan?
Every day became a balancing act between cautious hope and lingering fear.
Jenaya attended scans every two weeks, each visit a tense reminder that Toby’s life hung in the balance.
When Toby was finally born, Jenaya remembers a mix of relief and horror.
“At first, I thought it wasn’t that bad. But hours later, when I held him, the mass was extensive — patches, lumps, deep crevices on his arm and shoulder,” she recalls.
The reality was far from the benign growth they had hoped for.
Despite the overwhelming fear, Toby’s parents were determined to find answers.
He was referred to the Vascular Anomalies Clinic in Brisbane, but the anxiety never eased.
The scans suggested a rare vascular anomaly, likely benign, but intuition told the family otherwise.
They contacted the International Vascular Birthmarks Foundation in the US.
The response was urgent: this was not a typical hemangioma, and Toby required immediate attention.
Jenaya connected with a radiologist at Westmead Hospital in Sydney.
Within hours, Toby underwent evaluation, a biopsy, and a treatment plan was set in motion.
The biopsy revealed what Jenaya and Josh had feared: a malignant spindle cell neoplasm.
The oncology team explained it was likely infantile fibrosarcoma, a rare cancer affecting young children.
Jenaya remembers the moment vividly: “I couldn’t fully comprehend it. I was thinking, ‘Am I going to have to say goodbye to my baby before I’ve even really got to know him?’”
As the family began processing the diagnosis, new complications arose.
Jenaya and Toby were required to self-isolate due to potential COVID-19 exposure.
Floods in Queensland limited Josh’s ability to support them, leaving the family uncertain and anxious.
In the midst of this chaos, Toby underwent a PET scan to determine whether the cancer had spread.
Fortunately, the cancer was confined to his arm and shoulder.
Treatment began with chemotherapy through a central line, and the family returned to Queensland for ongoing care.
After two months, it became clear the initial regimen was not halting the tumor’s growth.
The mass was enlarging week by week, presenting an impossible choice: amputation of his arm or more intensive chemotherapy.
The decision weighed heavily on Jenaya, especially during her first Mother’s Day, forced to contemplate a procedure she could scarcely imagine for her three-month-old child.
Eventually, the chemotherapy plan was adjusted, and scans indicated the tumor was no longer growing.
Genetic testing revealed an extraordinary opportunity: Toby’s cancer was sensitive to crizotinib, a targeted therapy not yet widely used in children for sarcoma.
Initial regulations prevented immediate use, but the family pursued compassionate access.
After 11 months, Toby began treatment with crizotinib.
Seven months into therapy, scans showed remarkable results: the tumor had shrunk to just 2cm.
Toby was meeting all his developmental milestones.
Despite progress, the road ahead remains uncertain.
Jenaya and Josh live “scan to scan,” never fully knowing when treatment will end or what challenges lie ahead.
Their daily lives revolve around hospital visits, medication schedules, and the unpredictable nature of recovery.
Amid this uncertainty, they strive to embrace normal moments: walks, social interactions, and the small joys of life with a toddler.
Through their journey, Jenaya has become a passionate advocate for research into new treatments for childhood cancer.
She emphasizes the critical need for safer, more effective therapies.
Traditional chemotherapy, while life-saving, often inflicts profound side effects that threaten a child’s quality of life or even survival.
“It has broken my heart to hear of another child passing from something that isn’t even the cancer, but is something meant to save them,” she says.
“Our kids deserve safe and effective treatments.”
Toby’s story is more than a narrative of illness; it is a testament to human courage, parental devotion, and medical innovation.
From the first ultrasound revealing the mass, through weeks of uncertainty, intensive treatment, and unimaginable emotional strain, Toby and his family have faced each challenge with unwavering determination.
Their experience highlights not only the resilience of a child fighting for life but also the dedication of families navigating rare childhood cancers.
Every milestone Toby achieves — every reduction in tumor size, every developmental achievement, every smile — is the result of parental love, expert care, and emerging therapies that offer hope where there was once despair.
His journey underscores the importance of accessible clinical trials, compassionate support, and advocacy for innovative treatments that can save young lives.
Toby’s story is still being written.
While uncertainty remains, his progress offers hope to countless families facing similar battles.
It is a reminder that courage comes in many forms:
In the fragile body of a baby fighting cancer.
In the tireless love of parents navigating impossible decisions.
In the relentless pursuit of treatments that allow children to survive and thrive.
For Jenaya, Josh, and Toby, every day is a victory.
Every small triumph a testament to endurance.
Every step forward a beacon of hope in a journey that began in fear but continues with love, resilience, and belief in the power of modern medicine.
Toby’s story continues to inspire families, doctors, and researchers alike.
It reminds us that miracles are built not only from medicine but from the strength of human hearts refusing to give up.
From prenatal scans to life-saving therapies, from fear to cautious hope, Toby embodies the resilience and courage of a fighter.
His journey proves that even in the darkest moments, determination, love, and faith can illuminate a path forward.
Every hospital visit, every procedure, every tiny victory reinforces the impact of parental devotion and medical innovation.
Toby’s life shows us that even when the odds are stacked against us, hope can persist.
It grows stronger with each milestone, each smile, each moment of normalcy reclaimed.
And while the battle is not over, Toby’s story reminds the world that courage, love, and relentless hope can transform despair into life.
For Jenaya, Josh, and all families walking a similar path, Toby is living proof that bravery starts small, but its impact can be enormous.
Every scan, every therapy, every embrace carries the message: fight, survive, thrive.
Toby’s journey is far from complete, but his spirit — and the spirit of those who love him — shines brighter than any obstacle.
It is a story of hope, a testament to resilience, and a reminder that even the smallest fighters can inspire the world.